性健康市場：按產品類型、性別、分銷管道和地區分類

Sexual Health Market, By Product Type, By Gender, By Distribution Channel, By Geography

出版日期: 2026年04月15日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年性健康市場價值為456.7億美元，預計到2033年將達到829.4億美元。預計從2026年到2033年，該市場將以8.9%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	456.7億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	8.90%	預計金額（2033 年）	829.4億美元

性健康是個人身心健康的重要組成部分。它有助於擁有健康的性生活，避免性功能障礙，並有助於預防性性行為感染。相當一部分成年人患有一種或多種性功能障礙，包括性交疼痛、勃起功能障礙（ED）、性慾減退和早洩。根據美國國家生物技術資訊中心（NCBI）2016年的報告，性功能障礙極為普遍，影響全球約43%的女性和31%的男性。目前，有多種治療方法可用於解決這些性功能障礙並改善個人性健康，包括藥物治療、輔助設備和性治療。

市場動態

性功能障礙發生率和盛行率的不斷上升是市場成長的主要促進因素。導致性功能障礙的關鍵因素包括老化、壓力、不健康的生活方式以及其他心理因素。根據美國國家生物技術資訊中心 (NCBI) 於 2016 年 4 月發表的一項研究，性慾低下症 (HSDD) 影響著約 8.9% 的 18-44 歲女性和約 12.3% 的 45-64 歲女性。

此外，領先企業積極的產品研發正在推動創新高效治療方法的問世，以改善性健康。例如，2019年6月，AMAG 食品藥物管理局的Vyleesi（bremelanotide）獲得FDA核准，用於治療閉經女性獲得整體全身性性慾低下症（HSDD）。因此，監管核准的增加預計將推動性健康市場的成長。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本部分根據公司概況、產品系列、主要亮點、財務表現和策略等各種參數，對全球性健康市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球性健康市場》報告面向該行業的眾多相關人員，包括投資者、技術製造商、經銷商、性健康產品供應商、研究和諮詢公司、新進業者和金融分析師。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
公司簡介
- Teva Pharmaceutical Industries Ltd.
- Meda Pharmaceuticals, Inc.
- Eli Lilly &Company
- Bayer AG
- Vivus, Inc.
- Zydus Pharmaceuticals
- IVFTECH APS
- Merck &Co.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Novartis International AG
- Mylan Pharmaceuticals Inc.
- AstraZeneca

第9章

參考
分析方法

簡介目錄

Product Code: CMI3364

Sexual Health Market is estimated to be valued at USD 45.67 Bn in 2026 and is expected to reach USD 82.94 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 45.67 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.90%	2033 Value Projection:	USD 82.94 Bn

Sexual health is an important part of a person's physical and mental health. Sexual health leads to the healthy sexual life without any sexual dysfunctions, and preventive measures to avoid sexually transmitted infections. The adult population largely suffers from one or more sexual disorders such as dyspareunia, erectile dysfunctions, hypoactive sexual desire disorder, premature (early) ejaculation, and others. According to National Center for Biotechnology Information 2016, sexual dysfunction is highly prevalent, and affects around 43% of women and 31% of men, globally. Currently, various treatment options such as medication, mechanical aids, sexual therapies, and others are available for treating such sexual dysfunctions and to improve sexual health of the person.

Market Dynamics

Increasing incidence and prevalence of sexual disorders is a major factor augmenting growth of the market. Some of the major factors which cause sexual dysfunction are aging population, stressful and unhealthy lifestyle, and other psychological parameters. According to a study published in the National Center for Biotechnology Information in April 2016, hypoactive sexual desire disorder (HSDD) is present in around 8.9% and 12.3% women in the age group of 18 - 44 years and 45 - 64 years, respectively.

Moreover, robust product development activities by major key players is engaged in the introduction of innovative and highly effective drug treatment for improving sexual health. For instance, in June 2019, AMAG Pharmaceuticals received the U.S. FDA approval for Vyleesi (bremelanotide) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Thus, increasing approvals by regulatory authorities are expected to drive the growth of the sexual health market.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global sexual health market based on the following parameters - company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global sexual health market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the sexual health market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Global Sexual Health Market, By Product Type
- Erectile Dysfunction Drugs
- Gender Dysphoria Drugs
- Hypoactive Sexual Desire Disorder Drugs
- Premature Ejaculation Drugs
- Others
Global Sexual Health Market, By Gender
- Male
- Female
Global Sexual Health Market, By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Sexual Health Market, By Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players
- Eli Lilly and Company
- Viatris
- Bayer AG
- Organon & Co.
- Gilead Sciences
- ViiV Healthcare
- Perrigo Company plc
- Reckitt
- Church & Dwight Co., Inc.
- CooperSurgical
- LifeStyles Healthcare
- Karex Berhad

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Gender
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Merger and Acquisition
Regulatory Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Sexual Health Market, By Product Type, 2021- 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Erectile Dysfunction Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Gender Dysphoria Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Hypoactive Sexual Desire Disorder Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Premature Ejaculation Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Sexual Health Market, By Gender, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Sexual Health Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Sexual Health Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Meda Pharmaceuticals, Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Eli Lilly & Company
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bayer AG
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Vivus, Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Zydus Pharmaceuticals
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- IVFTECH APS
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sun Pharmaceutical Industries Ltd
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Novartis International AG
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Mylan Pharmaceuticals Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views